• Mashup Score: 0

    Once-daily (o.d.) formulations of MF/IND/GLY and MF/IND at different MF dose strengths

    Tweet Tweets with this article
    • #Mometasone/ #Indacaterol/ #Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus #Fluticasone Propionate/ #Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ #Tiotropium in #Patients with #Asthma https://t.co/9p4beYJkg8 https://t.co/4RNrN9k1D0

  • Mashup Score: 0

    Single-inhaler triple therapy with the extra-fine formulation of beclometasone, formoterol fumarate and glycopyrronium was cost-effective in adults with uncontrolled asthma, researchers reported in Respiratory Medicine. Martina Orlovic, MSc, PhD, director of global health economics and outcomes research at Chiesi Pharmaceuticals in Parma, Italy, and colleagues used data from the TRIMARAN

    Tweet Tweets with this article
    • Among adults with uncontrolled #asthma, extra-fine-formulation single-inhaler triple therapy with #beclometasone dipropionate, #formoterol fumarate and #glycopyrronium was cost-effective. @ResMedJournal @HealioAllergy https://t.co/sYScJfGP1K

  • Mashup Score: 0

    Single-inhaler triple therapy with the extra-fine formulation of beclometasone, formoterol fumarate and glycopyrronium was cost-effective in adults with uncontrolled asthma, researchers reported in Respiratory Medicine. Martina Orlovic, MSc, PhD, director of global health economics and outcomes research at Chiesi Pharmaceuticals in Parma, Italy, and colleagues used data from the TRIMARAN

    Tweet Tweets with this article
    • #ICYMI: Extra-fine-formulation single-inhaler triple therapy with #beclometasone dipropionate, #formoterol fumarate and #glycopyrronium was cost-effective among adults with uncontrolled #asthma. @ResMedJournal https://t.co/sYScJfGP1K

  • Mashup Score: 0

    Single-inhaler triple therapy with the extra-fine formulation of beclometasone, formoterol fumarate and glycopyrronium was cost-effective in adults with uncontrolled asthma, researchers reported in Respiratory Medicine. Martina Orlovic, MSc, PhD, director of global health economics and outcomes research at Chiesi Pharmaceuticals in Parma, Italy, and colleagues used data from the TRIMARAN

    Tweet Tweets with this article
    • Among adults with uncontrolled #asthma, extra-fine-formulation single-inhaler triple therapy with #beclometasone dipropionate, #formoterol fumarate and #glycopyrronium was cost-effective. @ResMedJournal @HealioAllergy https://t.co/buQuxyhgNe

    • Among adults with uncontrolled #asthma, extra-fine-formulation single-inhaler triple therapy with #beclometasone dipropionate, #formoterol fumarate and #glycopyrronium was cost-effective. @ResMedJournal @HealioAllergy https://t.co/5bn03EAjyU